Wai H Lim1, Stephen P McDonald, Graeme R Russ, Jeremy R Chapman, Maggie Km Ma, Henry Pleass, Bryon Jaques, Germaine Wong. 1. 1 Department of Renal Medicine, Sir Charles Gairdner Hospital, Western Australia, Australia. 2 Australia and New Zealand Dialysis and Transplant Registry, South Australia, Australia. 3 Central and Northern Adelaide Renal and Transplantation Services, South Australia, Australia. 4 Centre for Transplant and Renal Research, Westmead Hospital, New South Wales, Australia. 5 Department of Medicine, Queen Mary Hospital, Hong Kong. 6 Western Australia Kidney and Liver Transplant Service, Sir Charles Gairdner Hospital, Western Australia, Australia. 7 Centre for Kidney Research, The Children's Hospital at Westmead, New South Wales, Australia. 8 Sydney School of Public Health, University of Sydney, New South Wales, Australia.
Abstract
BACKGROUND: Delayed graft function (DGF) is an established complication after donation after cardiac death (DCD) kidney transplants, but the impact of DGF on graft outcomes is uncertain. To minimize donor variability and bias, a paired donor kidney analysis was undertaken where 1 kidney developed DGF and the other did not develop DGF using data from the Australia and New Zealand Dialysis and Transplant Registry. METHODS: Using paired DCD kidney data from the Australia and New Zealand Dialysis and Transplant Registry, we examined the association between DGF, graft and patient outcomes between 1994 and 2012 using adjusted Cox regression models. RESULTS: Of the 74 pairs of DCD kidneys followed for a median of 1.9 years (408 person-years), a greater proportion of recipients with DGF had experienced overall graft loss and death-censored graft loss at 3 years compared with those without DGF (14% vs 4%, P = 0.04 and 11% vs 0%, P < 0.01, respectively). Compared with recipients without DGF, the adjusted hazard ratio for overall graft loss at 3 years for recipients with DGF was 4.31 (95% confidence interval [95% CI], 1.13-16.44). The adjusted hazard ratio for acute rejection and all-cause mortality at 3 years in recipients who have experienced DGF were 0.98 (95% CI, 0.96-1.01) and 1.70 (95% CI, 0.36-7.93), respectively, compared with recipients without DGF. CONCLUSIONS: Recipients of DCD kidneys with DGF experienced a higher incidence of overall and death-censored graft loss compared with those without DGF. Strategies aim to reduce the risk of DGF could potentially improve graft survival in DCD kidney transplants.
BACKGROUND: Delayed graft function (DGF) is an established complication after donation after cardiac death (DCD) kidney transplants, but the impact of DGF on graft outcomes is uncertain. To minimize donor variability and bias, a paired donor kidney analysis was undertaken where 1 kidney developed DGF and the other did not develop DGF using data from the Australia and New Zealand Dialysis and Transplant Registry. METHODS: Using paired DCD kidney data from the Australia and New Zealand Dialysis and Transplant Registry, we examined the association between DGF, graft and patient outcomes between 1994 and 2012 using adjusted Cox regression models. RESULTS: Of the 74 pairs of DCD kidneys followed for a median of 1.9 years (408 person-years), a greater proportion of recipients with DGF had experienced overall graft loss and death-censored graft loss at 3 years compared with those without DGF (14% vs 4%, P = 0.04 and 11% vs 0%, P < 0.01, respectively). Compared with recipients without DGF, the adjusted hazard ratio for overall graft loss at 3 years for recipients with DGF was 4.31 (95% confidence interval [95% CI], 1.13-16.44). The adjusted hazard ratio for acute rejection and all-cause mortality at 3 years in recipients who have experienced DGF were 0.98 (95% CI, 0.96-1.01) and 1.70 (95% CI, 0.36-7.93), respectively, compared with recipients without DGF. CONCLUSIONS: Recipients of DCD kidneys with DGF experienced a higher incidence of overall and death-censored graft loss compared with those without DGF. Strategies aim to reduce the risk of DGF could potentially improve graft survival in DCD kidney transplants.
Authors: Longhui Qiu; Xingqiang Lai; Jiao-Jing Wang; Xin Yi Yeap; Shulin Han; Feibo Zheng; Charlie Lin; Zhuoli Zhang; Daniele Procissi; Deyu Fang; Lin Li; Edward B Thorp; Michael M Abecassis; Yashpal S Kanwar; Zheng J Zhang Journal: Kidney Int Date: 2020-08-18 Impact factor: 10.612
Authors: Yingxin Lin; Armando Teixeira-Pinto; Helen Opdam; Jeremy R Chapman; Jonathan C Craig; Natasha Rogers; Henry Pleass; Christopher Davies; Stephen McDonald; Jean Yang; Wai Lim; Germaine Wong Journal: Transplant Direct Date: 2022-05-13
Authors: Peter Urbanellis; Dagmar Kollmann; Ivan Linares; Sujani Ganesh; Fabiola Oquendo; Laura Mazilescu; Toru Goto; Yuki Noguchi; Rohan John; Ana Konvalinka; Istvan Mucsi; Anand Ghanekar; Darius Bagli; Markus Selzner; Lisa A Robinson Journal: Transplant Direct Date: 2020-07-22
Authors: Richard Dumbill; Roderick Jaques; Matthew Robb; Rachel Johnson; Rutger J Ploeg; Maria E Kaisar; Edward J Sharples Journal: J Clin Med Date: 2022-04-15 Impact factor: 4.964
Authors: Stein Foss; Espen Nordheim; Dag W Sørensen; Torgunn B Syversen; Karsten Midtvedt; Anders Åsberg; Thorleif Dahl; Per A Bakkan; Aksel E Foss; Odd R Geiran; Arnt E Fiane; Pål-Dag Line Journal: Transplant Direct Date: 2018-06-13